NOXO Appetite Control Balm Now Available

Share Article

NOXO Appetite Control Balm controls our drives and instincts and our ability to feel full. Smelling food can trigger instinctive or mindless behavior and we therefore put food in our mouth. The product is also available in a pleasant smelling Olfactory Nasal Inhaler

Adoodle, Inc, (OTC Pink Sheets: ADDE) announced today that NOXO Appetite Control balm is now available at a price of $ 10.95 for 20 doses on their new web site. Dr. Myron Yanoff an Advisory Board Member of Adoodle said " Now dieters can take control of their weight-loss programs and stay on the diets of their choice while getting through those difficult breakthrough periods"

The new natural appetite control balm, when applied topically, under the nostrils helps deliver scent molecules into the brain's olfactory nerves and then the limbic system, which is our emotional center. The limbic lobe activates the hypothalamus, which controls our drives and instincts and our ability to feel full. Smelling food can trigger instinctive or mindless behavior and we therefore put food in our mouth. The product is also available in a pleasant smelling Olfactory Nasal Inhaler.

An emotional state could also trigger a desire for food. NOXO Anti-Appetite replaces these triggers and gives us control, NOXO Appetite Control balm helps control appetite and all those irrational responses we have to food. NOXO Appetite Control balm used consciously gives us control of cravings where our own will power might fail.

NOXO Appetite control balm, a proprietary product formulation of 14 unique natural ingredients, which are soy-based, is absorbed into the skin and is not visible after application. Based on olfactory perception altering technology, the NOXO line of products is focused on modifying behavior, via the olfactory senses and the limbic system and results in a very effective weight loss product for natural appetite control.

About Adoodle
Adoodle’s NOXO division is focused on developing a variety of products that can modify behaviors such as appetite, stress, anxiety, mood, memory and sugar cravings. The company's first of eleven products to reach commercialization was NOXO’s Odor inhibitor, which has the ability to alter the brain’s ability to smell horrific odors. The odor is still there and it's not masked. The brain does not however, register its normal reaction to it. The uniquely formulated NOXO Odor Inhibitor is based on the advanced olfactory perception altering technology of all these new NOXO products.

For dealers and inquiries, please consider NOXO’s products to feature as part of your retail store, catalogue or service. Our headquarters are located in Pennsylvania where a seasoned team of business professionals develop winning strategies for products in the health and wellness industry. We are the exclusive manufacturer and/or wholesale distributor for these unique and effective products for modifying behavior. If you have questions or need additional information, please do not hesitate to call (484) 278-1626 or complete our online inquiry form at: http://www.noxoinfo.com/dealer
Investor & Media Relations:
Tel: 951-657-8840
email: adde(at)wsmg(dot)biz

Safe Harbor for Public Companies

Statements contained in this release that are not strictly historical are "forward-looking statements." Such forward-looking statements are sometimes identified by words such as "intends," "anticipates," "believes," "expects," and "hopes." The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include, but are not limited to, demand for the Company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders. Adoodle, "The Company" currently does not file periodic filings with the Securities and Exchange Commission but will publish financials on the Adoodle website as they become available.

Richard Stevenson
Adoodle, Inc
333 E. Lancaster Ave.
Suite 317
Wynnewood, PA 19096
USA

Phone: 484-278-1626

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

GERALD BRODSKY

610-952-8294
Email >